These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21773664)

  • 1. [Update on the treatment of Chagas' disease].
    Apt W; Zulantay I
    Rev Med Chil; 2011 Feb; 139(2):247-57. PubMed ID: 21773664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
    Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
    Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
    Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
    N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease.
    Paniz-Mondolfi AE; Pérez-Alvarez AM; Lanza G; Márquez E; Concepción JL
    Chemotherapy; 2009; 55(4):228-33. PubMed ID: 19451712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitrypanosomal therapy for chronic Chagas' disease.
    Bern C
    N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
    [No Abstract]   [Full Text] [Related]  

  • 10. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
    Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
    J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Part VI. Antiparasitic treatment for Chagas disease].
    B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ
    Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of Chagas disease chemotherapy.
    Guedes PM; Silva GK; Gutierrez FR; Silva JS
    Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allopurinol in the treatment of chronic Chagas' disease].
    Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
    Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
    [No Abstract]   [Full Text] [Related]  

  • 14. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment.
    Almeida DR; Carvalho AC; Branco JN; Pereira AP; Correa L; Vianna PV; Buffolo E; Martinez EE
    J Heart Lung Transplant; 1996 Oct; 15(10):988-92. PubMed ID: 8913915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.
    Murcia L; Carrilero B; Muñoz MJ; Iborra MA; Segovia M
    J Antimicrob Chemother; 2010 Aug; 65(8):1759-64. PubMed ID: 20542903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.
    Murcia L; Carrilero B; Albajar Viñas P; Segovia M
    Rev Esp Quimioter; 2012 Mar; 25(1):74-5. PubMed ID: 22488545
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
    Guedes PM; Urbina JA; de Lana M; Afonso LC; Veloso VM; Tafuri WL; Machado-Coelho GL; Chiari E; Bahia MT
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4286-92. PubMed ID: 15504854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of polymerase chain reaction (PCR) and hybridization assays to detect Trypanosoma cruzi in chronic chagasic patients treated with itraconazole or allopurinol.
    Zulantay I; Honores P; Solari A; Apt W; Ortiz S; Osuna A; Rojas A; López B; Sánchez G
    Diagn Microbiol Infect Dis; 2004 Apr; 48(4):253-7. PubMed ID: 15062917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nifurtimox, a bright future for treatment of Chagas disease].
    Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
    Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.